is president and managing partner of BioPlan Associates.
Annual study shows CMO technical expertise is not enough.
With budgets growing, clients see CMOs' costs as less crucial and consider other factors.
With budgets growing, clients see CMOs' costs as less crucial.
Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
In biopharmaceutical manufacturing, outsourcing and off-shoring have migrated into much more high-value areas.
A changing biopharmaceutical industry is going beyond typically outsourced activities and is using CMOs for more challenging processes. Review the top 10 outsourcing trends.
Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.
A CMO perspective on the CMO-client partnership.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva